Zacks Bull and Bear of the Day - Ad-Hoc-News (Pressemitteilung)

Zacks Bull and Bear of the Day
Ad-Hoc-News (Pressemitteilung), Germany - Apr 10, 2008
Vyvanse, the company's new flagship ADHD product, continues to perform very well and will be the key driver of the top-line. We maintain our Hold rating …

Find Out More:

Books:

Beyond Ritalin: Facts About Medication and Other Strategies for Helping Children, Adolescents, and Adults with Attention Deficit Disorders
The Attention Deficit Answer Book: The Best Medications and Parenting Strategies for Your Child
Bean Bag Activities & Coordination Skills: For Early Childhood & Adaptable for Special Education (CD)
Haze: An Asperger Novel
The ABA Program Companion: Organizing Quality Programs for Children With Autism and PDD

April 15th, 2008
Vyvanse

Truncated Domes

ADHD Boarding Schools

Pharmaceuticals GMP Procedures

Moving

Child Development

Autism Nutrition and Chelation

Natural ADHD Treatments

Golfshop

Discuss the topics raised by this article on the Myomancy Forum.

Google Search

Search Myomancy for news and information about ADHD, Dyslexia and Autism including diagnosis techniques, treatments and the science behind them.

Myomancy Treatment Database

A comprehensive list of every type of treatment available for ADHD, Autism and Dyslexia reviewed and rated by people who have tried them is available on the Myomancy Treatment Database. It covers mainstream treatments focusing on Reading as well as those less recognised using Biofeedback, Dietry and Rhythm. There are also treatments that deal with specific issues such as Audiotory, Visual, Balance, Coordination, Memory. Some treatments are provided as special centers whilst others are available via Books, CDs, DVDs or Software.

Read the latest on ADHD, Dyslexia and Autism from Myomancy via RSS 2.0 or use FeedBurner:

Myomancy ADHD, Dyslexia and Autism